Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

NCT02553642

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
Locations
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

NCT02908672

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Medical Center Orange, California, United States
View all 110 locations
View Trial Details
Completed

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

NCT05116202

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • City of Hope Duarte, California, United States
  • The Angeles Clinic and Research Institute - W LA Office Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 14 locations
View Trial Details
Completed

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

NCT02680184

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 13 locations
View Trial Details

Related conditions